These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3148149)

  • 41. Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients.
    Cassady SL; Thaker GK; Tamminga CA
    Psychopharmacol Bull; 1993; 29(2):235-40. PubMed ID: 8290671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
    Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
    Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
    Greil W; Auberger S; Haag H; Rüther E
    Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defect symptoms and abnormal involuntary movement in schizophrenia.
    Iager AC; Kirch DG; Jeste DV; Wyatt RJ
    Biol Psychiatry; 1986 Jul; 21(8-9):751-5. PubMed ID: 2873845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tardive dyskinesia and steady-state serum levels of thiothixene.
    Yesavage JA; Tanke ED; Sheikh JI
    Arch Gen Psychiatry; 1987 Oct; 44(10):913-5. PubMed ID: 2889439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship of circulating estradiol to tardive dyskinesia in men and postmenopausal women.
    Glazer WM; Naftolin F; Moore DC; Bowers MB; MacLusky NJ
    Psychoneuroendocrinology; 1983; 8(4):429-34. PubMed ID: 6144123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
    Tripodianakis J; Markianos M
    Pharmacopsychiatry; 1986 Sep; 19(5):365-7. PubMed ID: 3534900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia.
    Lieberman JA; Alvir J; Geisler S; Ramos-Lorenzi J; Woerner M; Novacenko H; Cooper T; Kane JM
    Neuropsychopharmacology; 1994 Oct; 11(2):107-18. PubMed ID: 7840862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects.
    McCreadie RG; MacDonald E; Wiles D; Campbell G; Paterson JR
    Br J Psychiatry; 1995 Nov; 167(5):610-7. PubMed ID: 8564316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
    J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral tardive dyskinesia: validation of a measuring device using digital image processing.
    Büchel C; de Leon J; Simpson GM; Gattaz WF
    Psychopharmacology (Berl); 1995 Jan; 117(2):162-5. PubMed ID: 7753962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Memory impairment in schizophrenic patients with tardive dyskinesia.
    Sorokin JE; Giordani B; Mohs RC; Losonczy MF; Davidson M; Siever LJ; Ryan TA; Davis KL
    Biol Psychiatry; 1988 Jan; 23(2):129-35. PubMed ID: 3334882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.
    Kinon BJ; Jeste DV; Kollack-Walker S; Stauffer V; Liu-Seifert H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):985-96. PubMed ID: 15380859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Zhang XY; Xiu MH; Chen DC; Zhu FY; Wu GY; Haile CN; Lu L; Kosten TA; Kosten TR
    J Psychiatr Res; 2010 May; 44(7):429-33. PubMed ID: 19932492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
    Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
    Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tardive dyskinesia: clinical and neuroendocrine response to low dose bromocriptine.
    Lenox RH; Weaver LA; Saran BM
    J Clin Psychopharmacol; 1985 Oct; 5(5):286-92. PubMed ID: 4044881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sodium valproate in tardive dyskinesia.
    Casey DE; Hammerstad JP
    J Clin Psychiatry; 1979 Nov; 40(11):483-5. PubMed ID: 385585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.